Davis Polk is advising Coloplast A/S on its acquisition of the outstanding shares of Uromedica, Inc., which will become a wholly owned subsidiary of Coloplast. Coloplast develops products and services to make life easier for people with deeply personal and private medical conditions. Coloplast’s business includes ostomy care, continence care, advanced wound care, interventional urology, and voice and respiratory care. Uromedica is a Minnesota-based medical device company that has developed long-term implantable balloon therapies for male and female stress urinary incontinence.
Read the full article: Coloplast to Aquire Uromedica //
Source: https://www.davispolk.com/experience/coloplast-acquisition-uromedica